Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade

Seong-Keun Yoo; Diego Chowell; Cristina Valero; Luc G T Morris; Timothy A Chan

doi:10.1001/jamanetworkopen.2022.0448

Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade

JAMA Netw Open. 2022 Feb 1;5(2):e220448. doi: 10.1001/jamanetworkopen.2022.0448.

Authors

Seong-Keun Yoo¹, Diego Chowell², Cristina Valero³, Luc G T Morris³, Timothy A Chan¹

Affiliations

¹ Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio.
² The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Abstract

This cohort study assesses the association between pretreatment body mass index in patients with 16 cancer types and immune checkpoint blockade treatment outcomes.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immune Checkpoint Inhibitors* / therapeutic use
Neoplasms* / complications
Neoplasms* / drug therapy
Obesity / complications
Programmed Cell Death 1 Receptor / therapeutic use

Substances

Immune Checkpoint Inhibitors
Programmed Cell Death 1 Receptor

Abstract

Publication types

MeSH terms

Substances

Grants and funding